Top 5 stories on co-infections and co-morbidities in people with HIV from IAS 2023
Top 5 HIV treatment stories from IAS 2023
Integrase inhibitors more likely to be linked to depression and suicidality than other HIV drugs
Top 5 stories on HIV in Africa from IAS 2023
Resistance history does not affect response to dolutegravir / lamivudine
Immediate ART associated with fewer deaths in Thailand, but starting a week or two later may lead to less virological failure
Injectable HIV treatment unlikely to be arriving soon in the global south
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases
Integrase inhibitors raise the risk of diabetes regardless of weight gain
